Good day everyone, Our coverage of CTXR at the end of last week yielded a potential gain for our members of 11% after closing at $2.20 on Friday. CTXR...
Citius Pharma (CTXR) Provides Current Information on its Pipeline and Indicates Potential Near-Term Catalysts
Update 05/03/21 CTXR now up over 20% following our coverage last week. "A rapid gain in market value can also release the sharks (short interest tra...
New Report Coming Tomorrow at Market Open on One of Our Favorite’s
We would not typically issue another report so soon after a big report like the last. However, the timing looks ideal for a potential squeeze. Good da...
Is the Biden Administration, Congress, and the FDA Declaring War on Nicotine? This $5 Stock Could Become a Home Run Overnight.
“22nd Century is in a very enviable – and near standalone - position to capitalize on the global combustible market that is valued at more than $700 b...
Be Ready for an Opportunity to Get Early Access to a Big 2021 Trading Story
"The wait is almost over, this report will be issued at the opening bell tomorrow, Monday 4/26/21."
Sphere 3D (NASDAQ: ANY) Tiny Float, Revenues Have Doubled Over the Last 3 Quarters and Seeking Acquisitions
"Sphere 3D (NASDAQ: ANY) Very High Growth Sector, Tiny float, Increasing Revenues and Seeking Acquisitions"
We Hope Everyone Enjoyed the Long Weekend. Trading Season is Kicking Off With a Great Jobs Report.
Welcome to all of our new group members, Market headline of the day: Stock futures jump as traders digest jobs report, look ahead to Fed remarks Stock...
Earnings Just Released After Hours Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) Report an 88% YOY Increase in Revenues!
GSMG posted 88% YoY revenue growth to 125 million USD, Net income is at 30M USD. Daily Average User growth YoY 250% to 5.1 million. Trading at less th...
Stock Market Indices, Cryptos, DE-FI, NFTs Where is it All Headed?
Potential New Report Coming Tomorrow: If things are developing the way we think they will, a new report will be issued after market close tomorrow, Mo...
Vanguard and Blackrock Lead a List of 42 Institutional Investor’s in this Company. Proprietary Biotech Actinium Pharma (NYSE: ATNM)
Update 3/25/21 (News out today) Actinium Announces Completion of Enrollment of Second Dose Cohort in Actimab-A Venetoclax Combination Trial for Patien...
